Genomic tests can help guide treatments for advanced cancers — based on your cancer genetic makeup — that may prolong survival or improve your quality of life.
Among the Best in the U.S. for Cancer Care
U.S. News & World Report ranked Rush University Medical Center’s Cancer Center among the best in the nation.
The Rush Approach to Precision Oncology
When you have an advanced cancer, precision oncology can help uncover new treatment options, even for cancers that had previously been considered untreatable. That's because we now know that that the effectiveness of cancer treatment often depends on your — and your cancer genes — genomic makeup.
Rush's experienced precision oncology team specializes in using genomic testing to help find treatments that may prolong survival or improve your quality of life.
As one of the few programs of its kind across the country, Rush’s precision oncology program is led by doctors who have shaped the field of precision oncology. They work with you and each other to develop a treatment plan based on your unique genomic makeup. This plan may include therapies that have been FDA-approved for other purposes or clinical trials.
How the Precision Oncology Program Works
Our precision oncology team won’t replace your primary oncologist; we’ll work closely alongside them. Here’s how our program works:
- Referral from your doctor: Your doctor can refer you to our program if you’re an adult with an advanced stage solid tumor or metastatic cancer. If you’re not sure whether you qualify, talk with your doctor.
- Your appointment: Your appointment will include an exam, a blood draw and, if needed, a biopsy to take a small sample of the tumor for genomic evaluation. You’ll also meet our team members and have plenty of time to ask them questions.
- Genomic testing: We’ll conduct comprehensive tests and analyses of your cancer to look for genomic features that might make certain treatments more or less effective.
- Expert review: Our precision oncology team — which includes medical oncologists, pathologists, radiation oncologists, surgical oncologists, pharmacists, computational biologists and other specialists — will meet to discuss your unique genomic profile and treatment needs.
- Personalized recommendations: We’ll develop personalized treatment recommendations that we’ll share with you and your primary oncologists. Your treatment plan may include therapies that have been FDA-approved for other purposes, or clinical trials available at Rush or elsewhere.
- Your decision: You can discuss our recommendations with your primary oncologist and decide whether you want to move forward. If you do move forward, we will work with you and your doctor to coordinate your care and start treatment.